Marked 2 months ago onto Eli Lilly Moves to Transform Sleep Disorder Treat…
Re-mark
Acquisition signals a major push to develop next-generation treatments for sleep disorders and neurological conditions In a significant move within the pharmaceutical industry, Eli Lilly has announced plans to acquire Centessa Pharmaceuticals, a biotech firm focused on developing innovative treatments for sleep-related disorders. The deal, valued at approximately $6.3 billion upfront, could rise further with milestone-based payments.
You may like
299.00
Plastic Is Dangerous: Why It’s Time to Switch to Stainless Steel
Plastic may be convenient, but it can come with…
Eco Spas provides superior Calgary hot tubs and spas that are built for comfort, relaxation, and year-round enjoyment…
How Healthcare Virtual Assistants Can Tame the Scheduling Rush
medical virtual assistant services, healthcare virtual assistant services, medical virtual assistant, healthcare virtual assistant, Medical Administrative Support